Apixaban and Ritonavir: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Apixaban and Ritonavir unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Apixaban interacts with Ritonavir

Ritonavir strongly inhibits CYP3A4 and P-glycoprotein, both important for apixaban clearance. Apixaban exposure and bleeding risk can increase substantially.

What you should do

Avoid or use label-directed dose reduction only when appropriate. Consider an anticoagulant that can be monitored or is less affected by CYP3A4/P-glycoprotein inhibition.

Key facts

Severity

Major — avoid combination

Mechanism

Ritonavir strongly inhibits CYP3A4 and P-glycoprotein, both important for apixaban clearance. Apixaban exposure and blee...

Action

Avoid or use label-directed dose reduction only when appropriate. Consider an anticoagulant that can be monitored or is ...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Apixaban and Ritonavir together?

No — this combination should generally be avoided. Avoid or use label-directed dose reduction only when appropriate. Consider an anticoagulant that can be monitored or is less affected by CYP3A4/P-glycoprotein inhibition.

What is the severity of this interaction?

The interaction between Apixaban and Ritonavir is classified as Major — avoid combination. Ritonavir strongly inhibits CYP3A4 and P-glycoprotein, both important for apixaban clearance. Apixaban exposure and bleeding risk can increase substantially.

What should I do if I'm prescribed both?

Avoid or use label-directed dose reduction only when appropriate. Consider an anticoagulant that can be monitored or is less affected by CYP3A4/P-glycoprotein inhibition. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.